There are 2789 resources available
1126P - Budget impact of Oncotype DX test compared to further gene expression tests in patients with early breast cancer in Germany
Presenter: Michael Lux
Session: ePoster Display
1127P - Cancer and Age Research Group (CARG) predicting chemotherapy toxicity in elderly patients with cancer
Presenter: Dalila Miraoui
Session: ePoster Display
1055P - Prognostic relevance of tumor-infiltrating lymphocytes in early-stage melanoma
Presenter: Eftychia Chatziioannou
Session: ePoster Display
1056P - Survival of patients with advanced melanoma according to first-line treatment and key prognostic factors: Real-world data from GEM1801 study
Presenter: Ivan Marquez-Rodas
Session: ePoster Display
1057P - ROS1 mutation can serve- as a potential efficacious predictor of immunotherapy in melanoma patients
Presenter: Hucheng Liu
Session: ePoster Display
1159P - Individualized methylation-based dynamic analysis of cell-free DNA in postoperative monitoring of resected lung cancer
Presenter: Kezhong Chen
Session: ePoster Display
1059P - 18F-FDG-PET/CT response assessment in patients with advanced melanoma treated with combination of low-dose ipilimumab and anti-PD1: A real-world experience
Presenter: Caio De Liz
Session: ePoster Display
1161P - Can 18F-FDG-PET/CT predict PD-L1 expression in resected non-small cell lung cancer (NSCLC)?
Presenter: Daniel Hughes
Session: ePoster Display
1135P - Impact of MCED screening interval on reduction in late-stage cancer diagnosis and mortality
Presenter: Peter Sasieni
Session: ePoster Display
1136P - A clinically applicable cervical cancer artificial intelligence screening system for accurate cytopathological diagnosis: A multicenter population-based study and randomized controlled trial
Presenter: Yunfang Yu
Session: ePoster Display
Resources:
Abstract